Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T18:50:57.748Z.
Calculation as of: 2026-10-06T18:50:57.748Z.
Quote observation: 2026-10-06T18:50:08.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 273f4a35489c6dcba82bfbf6813c8f243fa8fa5e32baf23fc33ea9a1b57f5f97
EARNINGS YIELD
N/A
Compass Therapeutics, Inc.
Market Cap
$180.99M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$180.89M
Earnings Yield
92.99%
TTM Avg
50.31%
3Y Avg
28.59%
5Y Avg
28.59%
Market Cap
$183.17M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$189.50M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$173.94M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | $180.99M | N/A | N/A | N/A | N/A |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $180.89M | 92.99% | 50.31% | 28.59% | 28.59% |
| Canton Strategic Holdings Inc (CNTN)vs › | $183.17M | N/A | N/A | N/A | N/A |
| AN2 Therapeutics, Inc. (ANTX)vs › | $184.04M | N/A | N/A | N/A | N/A |
| Yarrow Bioscience Inc (YARW)vs › | $178.83M | N/A | N/A | N/A | N/A |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.76M | N/A | N/A | N/A | N/A |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $189.50M | N/A | N/A | N/A | N/A |
| Journey Medical Corporation (DERM)vs › | $173.94M | N/A | N/A | N/A | N/A |
| RxSight, Inc. (RXST)vs › | $191.67M | N/A | N/A | N/A | N/A |
| Precision BioSciences, Inc. (DTIL)vs › | $171.13M | N/A | 12.15% | 12.15% | 12.15% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
